Extended-release carbamazepine versus lithium in management of acute mania in male inpatients with bipolar I disorder
INTRODUCTION: Since extended-release formulations of CBZ have been developed to decrease daily fluctuations in serum CBZ concentrations and improve dosing convenience, several large clinical trials have recently been conducted to assess the efficacy and tolerability of this form of CBZ in bipolar di...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2018-10-01
|
| Series: | Psychiatry and Clinical Psychopharmacology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/24750573.2018.1449181 |